Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering GMPs: Over 25% Of Consent Decree Steps Complete, Company Says

Executive Summary

Schering-Plough is over a quarter of the way through fulfilling its requirements under a 2002 consent decree

You may also be interested in...



Schering adds compliance exec

Former Lilly Chief Compliance Officer Lori Queisser takes over as Schering-Plough's Senior-VP Global Compliance & Business Practices starting Feb. 20. Schering's current compliance chief Brent Saunders is being promoted to Senior VP & President-Consumer Health Care effective June 1, where he will lead Schering's U.S. and Canadian consumer unit. Saunders joined the firm in November 2003 to serve in the then newly-created compliance position (1"The Pink Sheet" Oct. 13, 2003, p. 17). Schering is nearing completion of a compliance-related consent decree from 2002. Both Saunders and Queisser will report to CEO Fred Hassan...

Schering adds compliance exec

Former Lilly Chief Compliance Officer Lori Queisser takes over as Schering-Plough's Senior-VP Global Compliance & Business Practices starting Feb. 20. Schering's current compliance chief Brent Saunders is being promoted to Senior VP & President-Consumer Health Care effective June 1, where he will lead Schering's U.S. and Canadian consumer unit. Saunders joined the firm in November 2003 to serve in the then newly-created compliance position (1"The Pink Sheet" Oct. 13, 2003, p. 17). Schering is nearing completion of a compliance-related consent decree from 2002. Both Saunders and Queisser will report to CEO Fred Hassan...

Schering GMP Work Plan Is One-Third Complete; Toughest Battles Lie Ahead

The remaining two-thirds of Schering-Plough's GMP work plan contain the most challenging requirements under the company's 2002 manufacturing consent decree, CEO Fred Hassan told analysts Nov. 18

Related Content

UsernamePublicRestriction

Register

PS042633

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel